Ultragenyx Pharmaceutical: Q1 Earnings Insights

Ultragenyx Pharmaceutical RARE reported its Q1 earnings results on Thursday, May 4, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Ultragenyx Pharmaceutical missed estimated earnings by 17.68%, reporting an EPS of $-2.33 versus an estimate of $-1.98.

Revenue was up $20.56 million from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 10.03% increase in the share price the next day.

Here's a look at Ultragenyx Pharmaceutical's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-2.14	-1.81	-1.75	-1.76
EPS Actual	-2.16	-2.43	-2.26	-2.19
Revenue Estimate	105.12M	96.20M	87.51M	83.65M
Revenue Actual	103.35M	90.70M	89.34M	79.94M

To track all earnings releases for Ultragenyx Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar